Form 8-K - Current report:
SEC Accession No. 0001493152-23-012431
Filing Date
2023-04-17
Accepted
2023-04-17 06:15:12
Documents
17
Period of Report
2023-04-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41746
2 ex5-1.htm EX-5.1 15727
3 ex99-1.htm EX-99.1 277860
4 ex99-2.htm EX-99.2 135450
5 ex99-3.htm EX-99.3 10606
6 ex99-3_001.jpg GRAPHIC 3634
  Complete submission text file 0001493152-23-012431.txt   757052

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE gctk-20230413.xsd EX-101.SCH 2965
8 XBRL LABEL FILE gctk-20230413_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE gctk-20230413_pre.xml EX-101.PRE 22363
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3569
Mailing Address 301 RT 17 NORTH SUITE 800 RUTHERFORD NJ 07070
Business Address 301 RT 17 NORTH SUITE 800 RUTHERFORD NJ 07070 972 (8) 675-7878
GlucoTrack, Inc. (Filer) CIK: 0001506983 (see all company filings)

EIN.: 980668934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41141 | Film No.: 23822747
SIC: 3841 Surgical & Medical Instruments & Apparatus